174 related articles for article (PubMed ID: 12640302)
1. Prevention of kidney allograft rejection using anti-CD40 and anti-CD86 in primates.
Haanstra KG; Ringers J; Sick EA; Ramdien-Murli S; Kuhn EM; Boon L; Jonker M
Transplantation; 2003 Mar; 75(5):637-43. PubMed ID: 12640302
[TBL] [Abstract][Full Text] [Related]
2. Induction of allograft tolerance through costimulatory blockade: first selection of drugs in vitro.
Vierboom MP; Ossevoort M; Sick EA; Haanstra K; Jonker M
Transpl Immunol; 2003; 11(2):215-22. PubMed ID: 12799206
[TBL] [Abstract][Full Text] [Related]
3. No synergy between ATG induction and costimulation blockade induced kidney allograft survival in rhesus monkeys.
Haanstra KG; Sick EA; Ringers J; Wubben JA; Kuhn EM; 't Hart BA; Boon L; Jonker M
Transplantation; 2006 Nov; 82(9):1194-201. PubMed ID: 17102771
[TBL] [Abstract][Full Text] [Related]
4. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway.
Ossevoort MA; Ringers J; Kuhn EM; Boon L; Lorré K; van den Hout Y; Bruijn JA; de Boer M; Jonker M; de Waele P
Transplantation; 1999 Oct; 68(7):1010-8. PubMed ID: 10532543
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of costimulation allows for repeated systemic administration of adenoviral vector in rhesus monkeys.
Haegel-Kronenberger H; Haanstra K; Ziller-Remy C; Ortiz Buijsse AP; Vermeiren J; Stoeckel F; Van Gool SW; Ceuppens JL; Mehtali M; De Boer M; Jonker M; Boon L
Gene Ther; 2004 Feb; 11(3):241-52. PubMed ID: 14737083
[TBL] [Abstract][Full Text] [Related]
6. Treatment with humanized monoclonal antibodies against CD80 and CD86 combined with sirolimus prolongs renal allograft survival in cynomolgus monkeys.
Bîrsan T; Hausen B; Higgins JP; Hubble RW; Klupp J; Stalder M; Celniker A; Friedrich S; O'Hara RM; Morris RE
Transplantation; 2003 Jun; 75(12):2106-13. PubMed ID: 12829920
[TBL] [Abstract][Full Text] [Related]
7. Association of rapamycin and co-stimulation blockade using anti-B7 antibodies in renal allotransplantation in baboons.
Boulday G; Ashton-Chess J; Bernard P; Karam G; Vié H; Moreau A; Minault D; Lorré K; Soulillou JP; Blancho G
Nephrol Dial Transplant; 2004 Jul; 19(7):1752-60. PubMed ID: 15069178
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of murine corneal allograft rejection by treatment with antibodies to CD80 and CD86.
Kagaya F; Hori J; Kamiya K; Kaji Y; Oshika T; Amano S; Yamagami S; Tsuru T; Tanaka S; Matsuda H; Yagita H; Okumura K
Exp Eye Res; 2002 Jan; 74(1):131-9. PubMed ID: 11878826
[TBL] [Abstract][Full Text] [Related]
9. A novel fully human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys.
Imai A; Suzuki T; Sugitani A; Itoh T; Ueki S; Aoyagi T; Yamashita K; Taniguchi M; Takahashi N; Miura T; Shimamura T; Furukawa H; Todo S
Transplantation; 2007 Oct; 84(8):1020-8. PubMed ID: 17989608
[TBL] [Abstract][Full Text] [Related]
10. The role of B7 ligands (CD80 and CD86) in CD152-mediated allograft tolerance: a crosscheck hypothesis.
Tsai MK; Ho HN; Chien HF; Ou-Yang P; Lee CJ; Lee PH
Transplantation; 2004 Jan; 77(1):48-54. PubMed ID: 14724434
[TBL] [Abstract][Full Text] [Related]
11. Marked inhibition of transplant vascular sclerosis by in vivo-mobilized donor dendritic cells and anti-CD154 mAb.
Wang Z; Morelli AE; Hackstein H; Kaneko K; Thomson AW
Transplantation; 2003 Aug; 76(3):562-71. PubMed ID: 12923445
[TBL] [Abstract][Full Text] [Related]
12. Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation.
Pan H; Lu HM; Hu WM; Tian BL; Liu XB; Zhang ZD; Mai G
Transplant Proc; 2007 Dec; 39(10):3452-4. PubMed ID: 18089405
[TBL] [Abstract][Full Text] [Related]
13. Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation.
Montgomery SP; Xu H; Tadaki DK; Celniker A; Burkly LC; Berning JD; Cruzata F; Elster EA; Gray G; Kampen RL; Swanson SJ; Harlan DM; Kirk AD
Transplantation; 2002 Nov; 74(10):1365-9. PubMed ID: 12451232
[TBL] [Abstract][Full Text] [Related]
14. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
[TBL] [Abstract][Full Text] [Related]
15. Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates.
Kirk AD; Tadaki DK; Celniker A; Batty DS; Berning JD; Colonna JO; Cruzata F; Elster EA; Gray GS; Kampen RL; Patterson NB; Szklut P; Swanson J; Xu H; Harlan DM
Transplantation; 2001 Aug; 72(3):377-84. PubMed ID: 11502964
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing interleukin-4 prevents transplant arteriosclerosis mediated by indirect pathway T cells under CD40-CD154 costimulation blockade.
Spriewald BM; Ensminger SM; Bushell A; Wood KJ
Transplantation; 2008 Dec; 86(11):1615-21. PubMed ID: 19077898
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623
[TBL] [Abstract][Full Text] [Related]
18. Costimulation blockade followed by a 12-week period of cyclosporine A facilitates prolonged drug-free survival of rhesus monkey kidney allografts.
Haanstra KG; Sick EA; Ringers J; Wubben JA; Kuhn EM; Boon L; Jonker M
Transplantation; 2005 Jun; 79(11):1623-6. PubMed ID: 15940054
[TBL] [Abstract][Full Text] [Related]
19. Transient blocking of both B7.1 (CD80) and B7.2 (CD86) in addition to CD40-CD40L interaction fully abrogates the immune response following systemic injection of adenovirus vector.
Ziller C; Stoeckel F; Boon L; Haegel-Kronenberger H
Gene Ther; 2002 May; 9(9):537-46. PubMed ID: 11973629
[TBL] [Abstract][Full Text] [Related]
20. Long-term limb allograft survival using anti-CD40L antibody in a murine model.
Tung TH; Mackinnon SE; Mohanakumar T
Transplantation; 2003 Mar; 75(5):644-50. PubMed ID: 12640303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
